Onyx Healthcare Inc. (TPEX:6569)
92.00
+0.10 (0.11%)
Aug 19, 2026, 10:28 AM CST
Onyx Healthcare Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,452 | 1,313 | 1,241 | 1,493 | 1,600 | 1,202 |
Revenue Growth | 8.88% | 5.80% | -16.85% | -6.71% | 33.16% | -10.80% |
Gross Profit Gross Profit Growth | 477.22 | 434.02 | 456.28 | 556.14 | 472.31 | 363.73 |
Operating Income Operating Income Growth | 72.64 | 52.24 | 88.73 | 218.12 | 145.39 | 74.51 |
Net Income Net Income Growth | 183.65 | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 |
Earnings Per Share EPS Growth | 4.68 | 2.87 | 4.65 | 6.60 | 5.39 | 3.65 |
EPS Growth | 48.23% | -38.28% | -29.54% | 22.41% | 47.62% | -23.50% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 1,051 | 1,102 | 1,248 | 1,332 | 939.1 |
United States United States Growth | 543.86 | 293.13 | 515.86 | 664.98 | 545.52 |
Europe Europe Growth | 148.96 | 198.41 | 65.11 | - | - |
Write-Off Due to Consolidation Write-Off Due to Consolidation Growth | -430.07 | -352.1 | -336.53 | -461.41 | -345.13 |
Total Total Growth | 1,313 | 1,241 | 1,493 | 1,600 | 1,202 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 267.98 | 380.83 | 331.85 | 378.16 | 336.1 | 193.02 |
Total Debt Total Debt Growth | 390.12 | 292.84 | 250.98 | 206.74 | 191.92 | 315.55 |
Net Cash (Debt) Net Cash Growth | -122.14 | 87.99 | 80.87 | 171.42 | 144.18 | -122.53 |
Net Cash Growth | - | 8.80% | -52.82% | 18.89% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.11 | 2.25 | 2.08 | 4.43 | 3.83 | -3.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -31.69 | 161.78 | 124.52 | 350.49 | 161.79 | 17.13 |
Capital Expenditures CapEx Growth | -18.53 | -14.29 | -6.98 | -67.58 | -11.95 | -294.77 |
Free Cash Flow Free Cash Flow Growth | -50.22 | 147.49 | 117.53 | 282.91 | 149.84 | -277.64 |
Free Cash Flow Growth | - | 25.49% | -58.46% | 88.81% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.86% | 33.05% | 36.76% | 37.25% | 29.51% | 30.27% |
Operating Margin | 5.00% | 3.98% | 7.15% | 14.61% | 9.09% | 6.20% |
Pretax Margin | 14.12% | 9.28% | 16.63% | 20.43% | 15.12% | 11.66% |
Profit Margin | 12.64% | 8.54% | 14.57% | 17.10% | 12.68% | 10.61% |
FCF Margin | -3.46% | 11.23% | 9.47% | 18.95% | 9.36% | -23.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.500 | 2.500 | 4.000 | 4.348 | 4.348 | 3.479 |
Dividend Per Share Growth | -24.25% | -37.50% | -8.01% | 0% | 25.00% | -20.00% |
Dividend Yield | 2.70% | 2.38% | 2.82% | 3.19% | 5.82% | 4.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.62 | 38.15 | 32.66 | 22.58 | 16.03 | 24.79 |
Forward PE | - | 26.48 | 26.48 | 26.48 | 26.48 | 26.48 |
P/FCF Ratio | - | 29.01 | 50.27 | 20.37 | 21.71 | - |
PS Ratio | 2.47 | 3.26 | 4.76 | 3.86 | 2.03 | 2.63 |